Polycystic ovary syndrome (PCOS) affects up to 10% of women within reproductive ages and has been a cause of infertility and poor quality of life. Alteration in the oxidant-antioxidant profile occurs in PCOS. This study, therefore, investigates the contribution of ascorbic acid (AA) and alpha-tocopherol(ATE) on different PCOS parameters. The mifepristone and letrozole models were used, and young mature female mice were randomly assigned to groups of six per group. On PCOS induction with either mifepristone or letrozole, mice were administered AA and ATE at doses ranging from 10–1000mg/kg to 0.1–1000 mg/kg in the respective models. Vaginal cytology, body weights, and temperature, as well as blood glucose, testosterone, and insulin levels, were measured. Total antioxidant capacity and malondialdehyde levels were analyzed. Determination of gene expression of some reactive oxygen species and histomorphological analysis on the ovaries and uteri were performed. At the end of the experiments, AA and ATE restored reproductive cycling, with AA being more effective. AA and ATE increased fasting blood glucose but had no significant effect on serum insulin levels. AA decreased testosterone levels, but ATE caused slight increases. AA and ATE both increased total antioxidant capacity and decreased malondialdehyde levels. AA and ATE also slightly upregulated the mRNA expressions of catalase, superoxide dismutase, and heme oxygenase 1 mainly. AA and ATE also decreased ovarian weight and mostly resolved cysts in the ovaries and congestion in the uterus. This study has shown that AA and ATE are beneficial in the therapy of PCOS.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85:2434–8.
Knochenhauer ES, Key TJ, Kahsar-Miller M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078–82.
Lee JY, Baw C-K, Gupta S, et al. Role of oxidative stress in polycystic ovary syndrome. Curr Womens Health Rev. 2010;6:96–107.
Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352:1223–36.
Pasquali R, Gambineri A. Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age. In: An N Y Acad Sci. 2006, pp. 158–174.
Birdsall MA, Farquhar CM, White HD. Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann Intern Med. 1997;126:32–5.
Walters KA, Allan CM, Handelsman DJ. Rodent models for human polycystic ovary Syndrome1. Biol Reprod. 2012;86:2–7.
Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. Int J Women's Health. 2011;3:25–35.
Choi SH, Shapiro H, Robinson GE, Irvine J, Neuman J, Rosen B, et al. Psychological side-effects of clomiphene citrate and human menopausal gonadotrophin. J Psychosom Obstet Gynecol. 2005;26:93–100.
Verit FF, Erel O. Oxidative stress in nonobese women with polycystic ovary syndrome: correlations with endocrine and screening parameters. Gynecol Obstet Investig. 2008;65:233–9.
Kucukkurt I, Ince S, Fidan AF, et al. The effects of dietary supplementation of different amount of Yucca schidigera powder (Sarsaponin 30??) on blood and tissue antioxidant defense systems and lipid peroxidation in rats. J Anim Vet Adv. 2008;7:1413–7.
Keles H, Ince S, Küçükkurt I, Tatli II, Akkol EK, Kahraman C, et al. The effects of Feijoa sellowiana fruits on the antioxidant defense system, lipid peroxidation, and tissue morphology in rats. Pharm Biol. 2012;50:318–25.
Kolesnikova LI, Kolesnikov SI, Darenskaya MA, Grebenkina LA, Nikitina OA, Lazareva LM, et al. Activity of LPO processes in women with polycystic ovarian syndrome and infertility. Bull Exp Biol Med. 2017;162:320–2.
Troisi J, Cinque C, Giugliano L, et al. Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study. J Ovarian Res. 2019;12:25.
Szczuko M, Hawryłkowicz V, Kikut J, Drozd A. The implications of vitamin content in the plasma in reference to the parameters of carbohydrate metabolism and hormone and lipid profiles in PCOS. J Steroid Biochem Mol Biol. 2020;198:105570.
Umegaki K, Daohua P, Sugisawa A, Kimura M, Higuchi M. Influence of one bout of vigorous exercise on ascorbic acid in plasma and oxidative damage to DNA in blood cells and muscle in untrained rats. J Nutr Biochem. 2000;11:401–7.
Peters EM, Anderson R, Nieman DC, Fickl H, Jogessar V. Vitamin C supplementation attenuates the increases in circulating cortisol, adrenaline and anti-inflammatory polypeptides following ultramarathon running. Int J Sports Med. 2001;22:537–43.
Sudha S, Valli G, Mary Julie P, et al. Influence of streptozotocin-induced diabetes and insulin treatment on the pituitary-testicular axis during sexual maturation in rats. Exp Clin Endocrinol Diabetes. 2000;108:14–20.
Demirel MA, Ilhan M, Suntar I, Keles H, Kupeli Akkol E. Activity of Corylus avellana seed oil in letrozole-induced polycystic ovary syndrome model in rats. Rev Bras Farmacogn. 2016;26:83–8.
NIH. Public health service policy on humane care and use of laboratory animals. 2015. http://grants.nih.gov/grants/olaw/references/PHSPolicyLabAnimals.pdf.
National Research Council. Guide for the care and use of laboratory animals. In: Guide for the Care and Use of Laboratory Animals. Eighth ed. Washington D.C.: National Academies Press; 2010. p. 118.
Bafor EE, Onwukpa I, Itemire AO, Omoruyi O, Eferoba-Idio E, Odega K, et al. Amelioration of Escherichia coli-induced endometritis with ascorbic acid in non-pregnant mouse models. Am J Reprod Immunol. 2018;80:e12976.
Sanchez-Criado JE, Sanchez A, Ruiz A, et al. Endocrine and morphological features of cystic ovarian condition in antiprogesterone RU486-treated rats. Acta Endocrinol. 1993;129:237–45.
Reddy PS, Begum N, Mutha S, Bakshi V. Beneficial effect of Curcumin in Letrozole induced polycystic ovary syndrome. Asian Pac J Reprod. 2016;5:116–22.
Bafor EE, Ukpebor F, Elvis-offiah U, et al. Justicia flava leaves exert mild estrogenic activity in mouse models of uterotrophic and reproductive cycle investigations. J Med Food. 2020;23:395–408.
McLean AC, Valenzuela N, Fai S, et al. Performing vaginal lavage, crystal violet staining, and vaginal cytological evaluation for mouse estrous cycle staging identification. J Vis Exp. 2012;67:4389.
Ghowsi M, Khazali H, Sisakhtnezhad S. The effect of resveratrol on oxidative stress in the liver and serum of a rat model of polycystic ovary syndrome: an experimental study. Int J Reprod Biomed (Yadz). 2018;16:149–58.
Baranova A, Tran TP, Birerdinc A, Younossi ZM. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011;33:801–14.
Han ES, Muller FL, Pérez VI, Qi W, Liang H, Xi L, et al. The in vivo gene expression signature of oxidative stress. Physiol Genomics. 2008;34:112–26.
Alam MN, Bristi NJ, Rafiquzzaman M. Review on in vivo and in vitro methods evaluation of antioxidant activity. Saudi Pharm J. 2012;21:143–52.
Ruegg M a, Meinen S. Histopathology in Hematoxylin & Eosin stained muscle sections. TREAT-NMD Neuromuscul Netw 2012; 1–9.
Bradbury S. Peacock’s Elementary Microtechniques. 4th Ed: London: Arnold, 1974.
Osuka S, Nakanishi N, Murase T, Nakamura T, Goto M, Iwase A, et al. Animal models of polycystic ovary syndrome: a review of hormone-induced rodent models focused on hypothalamus-pituitary-ovary axis and neuropeptides. Reprod Med Biol. 2019;18:151–60.
Maliqueo M, Sun M, Johansson J, Benrick A, Labrie F, Svensson H, et al. Continuous administration of a P450 aromatase inhibitor induces polycystic ovary syndrome with a metabolic and endocrine phenotype in female rats at adult age. Endocrinology. 2013;154:434–45.
Chaudhari N, Dawalbhakta M, Nampoothiri L. GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile. Reprod Biol Endocrinol. 2018;16:1–13.
Wessel L, Balakrishnan-Renuka A, Henkel C, Meyer HE, Meller K, Brand-Saberi B, et al. Long-term incubation with mifepristone (MLTI) increases the spine density in developing Purkinje cells: new insights into progesterone receptor mechanisms. Cell Mol Life Sci. 2014;71:1723–40.
Gao Y, Short RV. Fertility control in laboratory rats and mice after feeding with the antigestagen RU486. J Reprod Fertil. 1994;101:477–81.
Ortega I, Sokalska A, Villanueva JA, Cress AB, Wong DH, Stener-Victorin E, et al. Letrozole increases ovarian growth and Cyp17a1 gene expression in the rat ovary. Fertil Steril. 2013;99:889–96.
Li J, Kim SJ, Abejuela VA, et al. Disrupted female estrous cyclicity in the intrahippocampal kainic acid mouse model of temporal lobe epilepsy. Epilepsia Open. 2017;2:39–47.
Banerji TK, Parkening TA, Collins TJ, Rassoli AH, Legate LS. Acute lithium treatment suppresses the proestrous LH surge in mice: chronic lithium leads to constant diestrus. Brain Res. 1986;380:176–80.
Bhatnagar AS, Häusler A, Schieweck K, Lang M, Bowman R. Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor. J Steroid Biochem Mol Biol. 1990;37:1021–7.
Miller WR. Biology of aromatase inhibitors: pharmacology/endocrinology within the breast. Endocr Relat Cancer. 1999;6:187–95.
Serpek B, Baspinar N, Haliloglu S, et al. The relationship between ascorbic acid, oestradiol 17β and progesterone in plasma and in ovaries during the sexual cycle in cattle. Rev Med Vet (Toulouse). 2001;152:253–60.
Luck MR, Zhao Y. Identification and measurement of collagen in the bovine corpus luteum and its relationship with ascorbic acid and tissue development. J Reprod Fertil. 1993;99:647–52.
Sebrell W, Harris R. The vitamins: chemistry, physiology, pathology and methods. New York: Academic Press; 1967.
Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. Int J Biomed Sci. 2008;43:334–44.
Tilly JL, Tilly KI. Inhibitors of oxidative stress mimic the ability of follicle-stimulating hormone to suppress apoptosis in cultured rat ovarian follicles. Endocrinology. 1995;136:242–52.
Igarashi M, Nishimura T, Izawa H. Augmentative effect of ascorbic acid upon induction of human ovulation in clomiphene ineffective anovulatory women. Fertil Steril. 1977;22:168–73.
Hódi Á, Földesi I, Ducza E, Hajagos-Tóth J, Seres AB, Klukovits A, et al. Tocopherol inhibits the relaxing effect of terbutaline in the respiratory and reproductive tracts of the rat: the role of the oxidative stress index. Life Sci. 2014;105:48–55.
Franks S, Adams J, Mason H, et al. Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynecol. 1985;12:605–32.
Kistner R. Induction of ovulation with clomiphene citrate (clomid). Obstet Gynecol Surv. 1965;20:873–900.
Badawy A, Abdel Aal I, Abulatta M. Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial. Fertil Steril. 2009;92:849–52.
Prelević GM, Wurzburger MI, Balint-Perić L, et al. Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries. Horm Res Paediatr. 1992;37:125–31.
Santosh HN, David CM. Role of ascorbic acid in diabetes mellitus: a comprehensive review. J Med Radiol Pathol Surg. 2017;4:1–3.
Eriksson J, Kohvakka A. Magnesium and ascorbic acid supplementation in diabetes mellitus. Ann Nutr Metab. 1995;39:217–23.
Ihara Y, Yamada Y, Toyokuni S, Miyawaki K, Ban N, Adachi T, et al. Antioxidant α-tocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes. FEBS Lett. 2000;473:24–6.
Savontaus E, Fagerholm V, Rahkonen O, Scheinin M. Reduced blood glucose levels, increased insulin levels and improved glucose tolerance in α2A-adrenoceptor knockout mice. Eur J Pharmacol. 2008;578:359–64.
Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998;83:2694–8.
Xu R, Zhang S, Tao A, Chen G, Zhang M. Influence of vitamin E supplementation on glycaemic control: a meta-analysis of randomised controlled trials. PLoS One. 2014;9:e95008.
Kafali H, Iriadam M, Ozardali I, et al. Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease. Arch Med Res. 2004;35:103–8.
Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7:219–31.
Mondul AM, Rohrmann S, Menke A, Feinleib M, Nelson WG, Platz EA, et al. Association of serum α-tocopherol with sex steroid hormones and interactions with smoking: implications for prostate cancer risk. Cancer Causes Control. 2011;22:827–36.
Hartman TJ, Dorgan JF, Woodson K, Virtamo J, Tangrea JA, Heinonen OP, et al. Effects of long-term α-tocopherol supplementation on serum hormones in older men. Prostate. 2001;46:33–8.
Kyle ME, Miccadei S, Nakae D, Farber JL. Superoxide dismutase and catalase protect cultured hepatocytes from the cytotoxicity of acetaminophen. Biochem Biophys Res Commun. 1987;149:889–96.
Montano MM, Jaiswal AK, Katzenellenbogen BS. Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-α and estrogen receptor-β. J Biol Chem. 1998;273:25443–9.
Morrissy S, Strom J, Purdom-Dickinson S, Chen QM. NAD(P)H: Quinone oxidoreductase 1 is induced by progesterone in cardiomyocytes. Cardiovasc Toxicol. 2012;12:108–14.
Mendoza CC, Calzada CA, Jiménez Z, et al. Possible Role of Nrf2 in oxidative and inflammatory processes during menopause: In: Morales-Gonzalez JA, Morales-Gonzalez A, Madrigal-Santillan EO (eds) A master regulator of oxidative stress—the transcription factor Nrf2. In Tech Open, 2016. 2016. https://doi.org/10.5772/65244.
Garg SK, Mahajan S. Effect of ascorbic acid on longevity, catalase and lipid peroxidation in Callosobruchus maculatus F. Age. 1993;16:87–92.
Richter HE, Loewen PC. Induction of catalase in Escherichia coli by ascorbic acid involves hydrogen peroxide. Biochem Biophys Res Commun. 1981;100:1039–46.
Dawson EB, Harris WA, Powell LC. Relationship between ascorbic acid and male fertility. World Rev Nutr Diet. 1990;62:1–26.
Jelodar G, Akbari A, Nazifi S. The prophylactic effect of vitamin C on oxidative stress indexes in rat eyes following exposure to radiofrequency wave generated by a BTS antenna model. Int J Radiat Biol. 2013;89:128–31.
Akbari A, Jelodar G, Nazifi S. Vitamin C protects rat cerebellum and encephalon from oxidative stress following exposure to radiofrequency wave generated by a BTS antenna model. Toxicol Mech Methods. 2014;24:347–52.
Dos Santos PS, Costa JP, Tomé ADR, et al. Oxidative stress in rat striatum after pilocarpine-induced seizures is diminished by alpha-tocopherol. Eur J Pharmacol. 2011;668:65–71.
Pellatt L, Hanna L, Brincat M, Galea R, Brain H, Whitehead S, et al. Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab. 2007;92:240–5.
Ekhard ZE, Koo WW, Nelson SE, et al. Lack of effect of graded doses of vitamin D on bone metabolism of breastfed infants. J Clin Nutr Metab. 2017;1:105.
Anderson N, Fergus RR, Nm C. Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries. Adv Nutr. 2001;2:78–88.
Abdulla KA, Um CY, Gross MD, Bostick RM. Circulating γ-tocopherol concentrations are inversely associated with antioxidant exposures and directly associated with systemic oxidative stress and inflammation in adults. J Nutr. 2018;148:1453–61.
The authors wish to acknowledge the support of Uloma B. Elvis-Offiah for her assistance at the start of the research.
Availability of Data and Material
Provided on request.
This research was supported by a grant from the Society for Reproductive Investigations and Bayer Discovery/Innovation Grant 2018/2019 to Dr. Enitome E. Bafor.
Conflict of Interest
The authors declare that they have no competing interests.
Ethical approval was provided by the Faculty of Pharmacy Research Ethics Committee University of Benin, Nigeria. Approval number: EC/FP/018/22.
Consent to Participate
Consent for Publication
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
About this article
Cite this article
Bafor, E.E., Uchendu, A.P., Osayande, O.E. et al. Ascorbic Acid and Alpha-Tocopherol Contribute to the Therapy of Polycystic Ovarian Syndrome in Mouse Models. Reprod. Sci. 28, 102–120 (2021). https://doi.org/10.1007/s43032-020-00273-9
- Polycystic ovarian syndrome